Age as a Modifier of the Effects of Sarcopenia on Survival Among Colon Cancer Patients Receiving Chemotherapy
Clinical Colorectal Cancer · 2025
DOI: 10.1016/j.clcc.2025.08.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Clinical Colorectal Cancer, 2025. Verfasst von Wen-Li Lin und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Affairs, Chi Mei Medical Center, Liouying, Tainan, Taiwan; School of Nursing, Fooyin University, Kaohsiung, Taiwan. Hauptthemen laut MEDLINE: Sarcopenia, Colonic Neoplasms, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Gefördert von: Kaohsiung Medical University, Chi Mei Medical Center.
Themen: Onkologische Pflege
Abstract (Originalsprache)
BACKGROUND: Sarcopenia is common among older adults and is associated with poor prognosis in several malignancies. This study evaluated whether sarcopenia serves as a survival risk factor among patients with colon cancer treated with chemotherapy, alongside the effects of age and visceral adiposity (VA). PATIENTS AND METHODS: We retrospectively recruited 133 patients diagnosed with resectable colon cancer who received chemotherapy between January 2014 and December 2017 at a teaching hospital. Computed tomography images were analyzed to assess body composition, and Kaplan-Meier survival curves and Cox proportional hazards regression models were used to assess survival. RESULTS: Patients receiving chemotherapy who were diagnosed with sarcopenia were associated with worse 5-year overall survival (OS: 87.3% vs. 65.4%) and longer hospital stay (19.1 vs. 15 days) compared with patients without sarcopenia. VA was not associated with OS or the length of hospital stay. There was a significant association between sarcopenia and OS, with a hazard ratio (HR) of 2.77 (95% confidence interval [CI]:1.42-5.38). The association remained after adjustment for other independent risk factors, including age > 70 years (adjusted HR: 1.98, 95% CI: 0.99-3.95) and alcohol consumption (adjusted HR: 8.96, 95% CI: 1.22-65.77). In age-stratified analyses, sarcopenia was an independent risk factor for worse OS (adjusted HR: 7.85, 95% CI: 1.05-58.91) among patients > 70 years but not among patients ≤ 70 years (adjusted HR: 2.01, 95% CI: 0.75-5.93). CONCLUSION: Sarcopenia is associated with improved OS, particularly in patients aged ≥ 70 years who underwent chemotherapy after resection of colorectal cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Affairs, Chi Mei Medical Center, Liouying, Tainan, Taiwan; School of Nursing, Fooyin University, Kaohsiung, Taiwan.
- School of Nursing, Kaohsiung Medical University, Kaohsiung, Taiwan; Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan. Electronic address: painting@kmu.edu.tw.
- Division of Hematology and Oncology, Department of Internal Medicine, Chi-Mei Medical Center, Liouying, Tainan, Taiwan. Electronic address: huangwentsung@me.com.
- Emergency Room, Chi-Mei Medical Center, Tainan, Taiwan. Electronic address: wenlilin2012@gmail.com.
Förderung
- Kaohsiung Medical University
- Chi Mei Medical Center
Zitieren
APA
Lin, W. L., Wu, L. M., Huang, W. T., & Chen, Y. P. (2025). Age as a Modifier of the Effects of Sarcopenia on Survival Among Colon Cancer Patients Receiving Chemotherapy. Clinical Colorectal Cancer. https://doi.org/10.1016/j.clcc.2025.08.002
Vancouver
Lin WL, Wu LM, Huang WT, Chen YP. Age as a Modifier of the Effects of Sarcopenia on Survival Among Colon Cancer Patients Receiving Chemotherapy. Clinical Colorectal Cancer. 2025. doi:10.1016/j.clcc.2025.08.002
BibTeX
@article{Lin2025,
author = {Lin, Wen-Li and Wu, Li-Min and Huang, Wen-Tsung and Chen, Yu-Pao},
title = {Age as a Modifier of the Effects of Sarcopenia on Survival Among Colon Cancer Patients Receiving Chemotherapy},
journal = {Clinical Colorectal Cancer},
year = {2025},
doi = {10.1016/j.clcc.2025.08.002}
}
EUVIMED